Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

696
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
696
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

616
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
616
An Overview of Psychoactive Drugs01:28

An Overview of Psychoactive Drugs

583
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
583
Altered States of Awareness01:06

Altered States of Awareness

1.0K
Altered states of consciousness represent significant deviations from one's normal mental state. These deviations can range from subtle changes in awareness to profound transformations in perception, thought processes, and sensory experiences. Altered states of consciousness can be triggered by various factors, including drug use, meditation, hypnosis, illness, or even intense fatigue.
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
1.0K
Evolutionary Psychology01:20

Evolutionary Psychology

942
Evolutionary psychology explores the origins of human behavior and mental processes by framing them within the context of natural selection, a theory famously propounded by Charles Darwin. This field asserts that many behaviors common across human societies — ranging from instinctive fear reactions to complex social interactions — arose as evolutionary adaptations. These adaptations enhanced the survival and reproductive success of our ancestors, thereby becoming embedded in the...
942
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

916
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
916

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On Minimizing Risk and Harm in the Use of Psychedelics.

Psychiatric research and clinical practice·2025
Same author

A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.

Psychedelic medicine (New Rochelle, N.Y.)·2025
Same author

Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model.

Frontiers in psychology·2022
Same author

Leveraging a public-public partnership in Los Angeles County to address COVID-19 for children, youth, and families in underresourced communities.

Psychological trauma : theory, research, practice and policy·2020
Same author

Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities.

Public health genomics·2016
Same author

Tolerability of fluticasone furoate/vilanterol combination therapy in children aged 5 to 11 years with persistent asthma.

Clinical therapeutics·2014

Related Experiment Video

Updated: Jan 17, 2026

The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders
10:08

The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders

Published on: August 25, 2022

3.3K

Psychedelic training program development: lessons from the evolution of the EMBARK program.

William Brennan1, Melissa Field2, Catherine Schon3

  • 1Consultant, New York, NY, United States.

Frontiers in Psychology
|September 19, 2025
PubMed
Summary

This study details the EMBARK training program for psychedelic therapy session monitors. It highlights iterative development, lessons learned, and AI integration for enhanced clinical trial support.

Keywords:
EMBARK model of psychedelic treatmentevidence-based training approachespsychedelic medicinepsychedelic therapypsychedelic treatmentstraining program development

More Related Videos

Combined Shuttle-Box Training with Electrophysiological Cortex Recording and Stimulation as a Tool to Study Perception and Learning
08:43

Combined Shuttle-Box Training with Electrophysiological Cortex Recording and Stimulation as a Tool to Study Perception and Learning

Published on: October 22, 2015

10.7K
A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

10.1K

Related Experiment Videos

Last Updated: Jan 17, 2026

The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders
10:08

The Evoked Potential Operant Conditioning System EPOCS: A Research Tool and an Emerging Therapy for Chronic Neuromuscular Disorders

Published on: August 25, 2022

3.3K
Combined Shuttle-Box Training with Electrophysiological Cortex Recording and Stimulation as a Tool to Study Perception and Learning
08:43

Combined Shuttle-Box Training with Electrophysiological Cortex Recording and Stimulation as a Tool to Study Perception and Learning

Published on: October 22, 2015

10.7K
A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

10.1K

Area of Science:

  • Psychedelic Medicine
  • Clinical Trial Training
  • Healthcare Professional Development

Background:

  • The burgeoning field of psychedelic medicine requires standardized training for healthcare providers.
  • Developing evidence-based competencies is crucial for safe and effective psychedelic treatments.
  • Cybin, Inc. developed the EMBARK training program to address these needs for clinical trial session monitors.

Purpose of the Study:

  • To describe the iterative development of the EMBARK training program for psychedelic clinical trial session monitors.
  • To detail the program's evolution through three phases, including components, successes, and lessons learned.
  • To discuss innovations in EMBARKCT, the latest version used in Phase 3 trials, including AI integration.

Main Methods:

  • Iterative development methodology across three distinct phases.
  • Incorporation of feedback and data from completed and ongoing clinical trials.
  • Integration of artificial intelligence (AI) with human oversight in the EMBARKCT iteration.

Main Results:

  • The EMBARK training program has been successfully implemented in multiple clinical trials.
  • The iterative process allowed for refinement based on practical application and identified needs.
  • EMBARKCT incorporates AI to proactively identify support and training requirements for session monitors.

Conclusions:

  • The EMBARK program provides a robust model for training psychedelic therapy session monitors.
  • Iterative development and AI integration enhance the quality and effectiveness of training.
  • The findings offer valuable insights and recommendations for standardizing psychedelic medicine training nationally and globally.